Less than one-fifth of women are correctly diagnosed suitably early with menopause, the report, published May 15 by Elektra Health, a digital women’s health platform, showed. Even with a correct diagnosis, many women are subjected to wasteful testing and care before getting appropriate treatment.
Women with a clinical diagnosis of menopause incur approximately 45 percent more healthcare costs annually than those who don’t, the report said. But even with a correct diagnosis, a lack of appropriate care often results in women seeking additional specialty care and testing, which can drive costs higher, according to the report.
“Menopause is directly correlated to several high-cost drivers in women’s healthcare,” said Alessandra Henderson, CEO and co-founder of Elektra Health. “Early interventions and preventative care are critical to drive long-term health outcomes and lower costs but, ultimately, menopause is a massive cost hiding in plain sight, especially for health plans and employers.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
